Bristol Myers Squibb (BMS) is a global biopharmaceutical company that conducts research on the International Space Station (ISS). BMS leverages the microgravity environment of space to improve the crystallization of biotherapeutic compounds, aiming to enhance drug stability, streamline manufacturing processes, and improve drug delivery methods. They partner with organizations like Redwire and utilize platforms like PIL-BOX for their space-based research, with the ISS National Lab and SpaceX facilitating their access to space. Their work focuses on oncology, immunology, and cardiovascular disease, seeking to develop improved medicines for patients.
All verified mentions of this organization in source documents.
Redwire supports partners including Aspera Biomedicines, Bristol Myers Squibb, Eli Lilly and Company, ExesaLibero Pharma, Purdue University, and Butler University.
Redwire launched 12 additional PIL-BOX units onboard the SpaceX-31 cargo resupply mission to the ISS with partners Bristol Myers Squibb and ExesaLibero Pharma.
Redwire is launching a PIL-BOX investigation to the International Space Station in partnership with Bristol Myers Squibb.